Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies (NYSE: MIR) has established a significant partnership with the International Atomic Energy Agency (IAEA) to enhance global radiation safety initiatives. The collaboration focuses on strengthening radiation detection and measurement capabilities at the IAEA's Terrestrial Environmental Radiochemistry (TERC) Laboratory.
As the first corporation to enter a Practical Arrangement with the IAEA TERC Laboratory, Mirion will contribute through multiple key initiatives: active collaboration on TERC Laboratory projects, training and capacity building, measurement assistance, and support of an annual intern through the "Mirion Scholarship." The company will also provide an in-kind donation of instrumentation and software for training and analysis purposes.
The partnership builds on Mirion's existing engagement with IAEA, including training representatives from over 100 Member States for the IAEA's Worldwide Proficiency Test Exercise scheme.
Mirion Technologies (NYSE: MIR) reported strong Q2 2025 financial results, with revenue increasing 7.6% to $222.9 million. The company achieved a significant turnaround with GAAP net income of $8.5 million, compared to a $12.0 million loss in Q2 2024. Adjusted EBITDA grew 4.9% to $51.2 million.
Following these results, Mirion raised its 2025 guidance, now projecting revenue growth of 7.0% - 9.0% (up from 5.0% - 7.0%) and adjusted EBITDA of $223-233 million. The company also completed strategic initiatives including a $400 million convertible notes offering, Term Loan B refinancing, and the acquisition of Certrec to expand its nuclear power services.
The company maintains strong positioning in nuclear power and cancer care markets, with management expressing confidence in capturing favorable market trends despite some end-market adjustments in Labs & Research and Dosimetry segments.Mirion (NYSE: MIR) has announced the acquisition of Certrec, a leading regulatory compliance and digital integration solutions provider for the energy industry, for $81 million plus equity incentives. The deal represents a 16.9x EV/2025E EBITDA multiple.
Certrec, based in Fort Worth, TX, has been serving power-generating facilities since 1988, with its solutions currently employed by every US nuclear reactor facility and over 80 entities across North America. The company specializes in regulatory compliance management with the Nuclear Regulatory Commission (NRC) and North American Electric Reliability Corporation (NERC).
The acquisition will strengthen Mirion's Nuclear & Safety group, enhancing its digital ecosystem and expanding its offerings in the nuclear power market.
Mirion (NYSE: MIR) has scheduled its second quarter 2025 financial results release for Thursday, July 31, 2025, after market close. The company will host a conference call to discuss the results on Friday, August 1, 2025, at 10:00 am ET.
Investors can access the call through two dial-in numbers: 1-877-407-9208 (domestic) or 1-201-493-6784 (international). A live webcast will be available on Mirion's investor relations website. A replay will be accessible until August 15, 2025, using the access code 13754545.
[]Mirion Technologies (NYSE: MIR) and Westinghouse Electric Company have formed a strategic partnership to provide digital Ex-core Nuclear Instrumentation Systems based on Mirion's proTK product line. The collaboration aims to upgrade existing analog neutron flux monitoring systems in nuclear power plants.
The digital upgrade solution, offered exclusively through Westinghouse for Westinghouse and Combustion Engineering designed PWRs worldwide, will replace outdated equipment from the 1960s. Mirion's proTK technology has demonstrated reliability with over 400 drawers implemented globally, accumulating more than 4000 operating years of performance across nuclear facilities.
Mirion Technologies reported strong Q1 2025 financial results, with revenues increasing 4.9% to $202.0 million. The company achieved a significant turnaround, posting a GAAP net income of $0.4 million compared to a $26.5 million loss in Q1 2024.
Key highlights include:
- Adjusted EBITDA rose 18% to $46.7 million
- Adjusted earnings per share improved to $0.10 from $0.06
- Total orders increased 11.5% to $203 million
The company updated its 2025 guidance, projecting revenue growth of 5.0-7.0% and organic revenue growth of 5.5-7.5%. Despite new tariff impacts and U.S. government funding reductions, Mirion reaffirmed its Adjusted EBITDA target of $215-230 million and Adjusted EPS guidance of $0.45-$0.50 per share.
Mirion Technologies (NYSE: MIR) has scheduled its first quarter 2025 financial results release for Tuesday, April 29, 2025, after market close. The company will host a conference call on Wednesday, April 30, 2025, at 11:00 am ET to discuss the quarterly performance.
Investors can join the earnings call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international). A live webcast will be available on the company's investor relations website. A replay of the call will be accessible until May 14, 2025, via phone using access code 13753466 or through Mirion's IR website.
Mirion Technologies (NYSE: MIR) has launched version 1.2 of its Apex-Guard gamma spectroscopy software, enhancing quality control in radiopharmaceutical production. The updated software introduces a patent-pending algorithm for Radionuclidic purity measurements, supporting compliance with FDA regulations.
The release comes amid rapid expansion in the radiopharmaceutical sector, with over 100 drugs in Phase I or further clinical development. The software builds upon Mirion's Genie™ and Apex-Gamma™ platforms, offering advanced controls, security, and audit features. It integrates with BioTrax QMS®, an electronic quality management system from ec2 Software, a Mirion Medical Company.
This enhancement aims to streamline quality management processes and ensure compliance in radioisotope production, particularly important for cancer care applications.
Mirion Technologies (NYSE: MIR) has secured contracts to provide critical systems for TerraPower's Natrium Reactor Demonstration Project in Wyoming, the first commercial advanced nuclear power plant in the U.S. The project, a public-private partnership between TerraPower and the U.S. Department of Energy, will implement Natrium technology combining a sodium-cooled fast reactor with molten salt energy storage.
Mirion will deliver two key systems:
- Radiation Monitoring System (RMS) featuring area, effluent, and process radiation monitors for continuous plant safety monitoring
- Nuclear Instrumentation System (XIS) for detecting reactor power levels
The contracts position Mirion to support innovative nuclear technologies, including small and advanced modular reactors, contributing to meeting modern energy demands with safe, sustainable nuclear power.
FAQ
What is the current stock price of Mirion Technologies (MIR)?
What is the market cap of Mirion Technologies (MIR)?
